外体冲击波治疗与外围动脉疾病相关的间歇性关节:系统性审查和元分析
Peiyuan Tang1,2, Ting Wen1,2, Jingyue Su3,4
1Deparment of Orthopedics, Xiangya Hospital, Central South University, Hunan, China.
Annals of medicine
|August 7, 2025
概括
体外冲击波疗法 (ESWT) 显著改善了间歇性听 (IC) 患者的步行距离和生活质量. 由于样本规模较小,需要进行进一步的研究.
科学领域:
- 血管医学 血管医学
- 再生医学是一种再生医学.
- 非侵入性疗法 非侵入性疗法
背景情况:
- 间歇性音 (IC) 是外周动脉疾病的常见症状.
- 目前对IC的治疗有局限性.
- 身体外冲击波疗法 (ESWT) 提供了一个潜在的非侵入性治疗选择.
研究的目的:
- 评估ESWT对患有IC的患者的疗效.
- 综合现有关于ESWT对IC患者功能结果和生活质量影响的证据.
主要方法:
- 对八项研究进行了系统审查和元分析.
- 搜索了PubMed,Embase,Cochrane图书馆和科学网络的数据库.
- 分析了332名使用Review Manager 5.4的患者的数据;评估了GRADE的证据强度.
主要成果:
- 与安慰剂相比,ESWT显著增加了无疼痛步行距离 (MD=26.53) 和最大步行距离 (MD=37.21) (p < 0.01).
- 生活质量有所改善,由更高的EQ-5D-3L得分 (MD=0.08) 和SF-36域增强 (p <0.01) 表示.
- 在脚-手臂指数 (ABI) (MD=-0.01,p = 0.05) 中没有观察到显著变化.
结论:
- ESWT在改善IC患者的行走能力和生活质量方面表现出有效性.
- 研究结果表明,ESWT是对外围动脉疾病症状的有希望的治疗方法.
- 需要对更大样本进行进一步的调查,以确认这些结果.
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35
01:26Peripheral Artery Disease IV: Nursing Management
44
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
44
01:30Peripheral Artery Disease I: Introduction
33
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33
01:23Peripheral Artery Disease V: Postoperative Nursing Management
25
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
25
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
254
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
254